Literature DB >> 22563138

The consequences of yield stress on deployment of a non-Newtonian anti-HIV microbicide gel.

Savas Tasoglu1, Su Chan Park, Jennifer J Peters, David F Katz, Andrew J Szeri.   

Abstract

A recent study in South Africa has confirmed, for the first time, that a vaginal gel formulation of the antiretroviral drug Tenofovir, when applied topically, significantly inhibits sexual HIV transmission to women [10]. However the gel for this drug, and anti-HIV microbicide gels in general, have not been designed using full understanding of how gel spreading and retention in the vagina govern successful drug delivery. Elastohydrodynamic lubrication theory can be applied to model such spreading of microbicide gels, which are inherently non-Newtonian [13,15]. A yield stress is emerging as one of the important properties of microbicide gel vehicle deployment, as this may improve retention within the vaginal canal. On the other hand, a yield stress may decrease the initial extent of the coating flow. Here, we first explain a certain yield stress paradox observed generally in many lubrication flows. Four conditions are determined, via scaling analysis, which mitigate the inconsistency in the use of lubrication theory to analyze the specific problem of elastic wall squeezing flow of yield stress fluid. Parameters characterizing these conditions are obtained experimentally for a test gel. Using them, it is shown that the lubrication approximation may be applied to the elastic wall-squeezing problem for this gel.

Entities:  

Year:  2011        PMID: 22563138      PMCID: PMC3342340          DOI: 10.1016/j.jnnfm.2011.06.007

Source DB:  PubMed          Journal:  J Nonnewton Fluid Mech        ISSN: 0377-0257            Impact factor:   2.670


  17 in total

Review 1.  Microbicides: a new approach to preventing HIV and other sexually transmitted infections.

Authors:  Alan Stone
Journal:  Nat Rev Drug Discov       Date:  2002-12       Impact factor: 84.694

2.  Gravity-induced coating flows of vaginal gel formulations: in vitro experimental analysis.

Authors:  Sarah L Kieweg; Anthony R Geonnotti; David F Katz
Journal:  J Pharm Sci       Date:  2004-12       Impact factor: 3.534

3.  The effects of inhomogeneous boundary dilution on the coating flow of an anti-HIV microbicide vehicle.

Authors:  Savas Tasoglu; Jennifer J Peters; Su Chan Park; Stéphane Verguet; David F Katz; Andrew J Szeri
Journal:  Phys Fluids (1994)       Date:  2011-09-15       Impact factor: 3.521

4.  Design of a semisolid vaginal microbicide gel by relating composition to properties and performance.

Authors:  Alamelu Mahalingam; Eric Smith; Judit Fabian; Festo R Damian; Jennifer J Peters; Meredith R Clark; David R Friend; David F Katz; Patrick F Kiser
Journal:  Pharm Res       Date:  2010-09-15       Impact factor: 4.200

5.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

6.  Elastohydrodynamics of the eyelid wiper.

Authors:  M B Jones; G R Fulford; C P Please; D L S McElwain; M J Collins
Journal:  Bull Math Biol       Date:  2007-12-08       Impact factor: 1.758

7.  Dilution of microbicide gels with vaginal fluid and semen simulants: effect on rheological properties and coating flow.

Authors:  Bonnie E Lai; Yao Quan Xie; Michael L Lavine; Andrew J Szeri; Derek H Owen; David F Katz
Journal:  J Pharm Sci       Date:  2008-02       Impact factor: 3.534

8.  A model of transluminal flow of an anti-HIV microbicide vehicle: Combined elastic squeezing and gravitational sliding.

Authors:  Andrew J Szeri; Su Chan Park; Stéphane Verguet; Aaron Weiss; David F Katz
Journal:  Phys Fluids (1994)       Date:  2008-08-21       Impact factor: 3.521

9.  Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.

Authors:  Bonnie E Lai; Anthony R Geonnotti; Michael G Desoto; David C Montefiori; David F Katz
Journal:  Antiviral Res       Date:  2010-08-13       Impact factor: 5.970

10.  Interpreting properties of microbicide drug delivery gels: analyzing deployment kinetics due to squeezing.

Authors:  Sarah L Kieweg; David F Katz
Journal:  J Pharm Sci       Date:  2007-04       Impact factor: 3.534

View more
  7 in total

Review 1.  Vaginal drug distribution modeling.

Authors:  David F Katz; Andrew Yuan; Yajing Gao
Journal:  Adv Drug Deliv Rev       Date:  2015-04-28       Impact factor: 15.470

2.  Transient swelling, spreading, and drug delivery by a dissolved anti-HIV microbicide-bearing film.

Authors:  Savas Tasoglu; Lisa C Rohan; David F Katz; Andrew J Szeri
Journal:  Phys Fluids (1994)       Date:  2013-03-04       Impact factor: 3.521

3.  Gravity-Driven Thin Film Flow of an Ellis Fluid.

Authors:  Vitaly O Kheyfets; Sarah L Kieweg
Journal:  J Nonnewton Fluid Mech       Date:  2013-12-01       Impact factor: 2.670

4.  Transient spreading and swelling behavior of a gel deploying an anti-HIV topical microbicide.

Authors:  Savas Tasoglu; David F Katz; Andrew J Szeri
Journal:  J Nonnewton Fluid Mech       Date:  2012-11       Impact factor: 2.670

Review 5.  Manipulating biological agents and cells in micro-scale volumes for applications in medicine.

Authors:  Savas Tasoglu; Umut Atakan Gurkan; Shuqi Wang; Utkan Demirci
Journal:  Chem Soc Rev       Date:  2013-07-07       Impact factor: 54.564

6.  Vaginal deployment and tenofovir delivery by microbicide gels.

Authors:  Y Gao; A Yuan; O Chuchuen; A Ham; K H Yang; D F Katz
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

7.  User preferences in a carrageenan-based vaginal drug delivery system.

Authors:  Bangde Li; Toral Zaveri; Gregory R Ziegler; John E Hayes
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.